Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Medifast (MED) Shares Repurchased (2018 - 2023)

Medifast (MED) has disclosed Shares Repurchased for 9 consecutive years, with $3.6 million as the latest value for Q1 2023.

  • For the quarter ending Q1 2023, Shares Repurchased fell 63.98% year-over-year to $3.6 million, compared with a TTM value of $3.6 million through Dec 2023, down 97.15%, and an annual FY2023 reading of $3.6 million, down 97.15% over the prior year.
  • Shares Repurchased was $3.6 million for Q1 2023 at Medifast, down from $6.4 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $110.0 million in Q2 2022 and bottomed at $3.6 million in Q1 2023.
  • Average Shares Repurchased over 4 years is $23.2 million, with a median of $10.0 million recorded in 2022.
  • The sharpest move saw Shares Repurchased soared 799.82% in 2022, then plummeted 63.98% in 2023.
  • Year by year, Shares Repurchased stood at $23.1 million in 2019, then tumbled by 56.74% to $10.0 million in 2021, then crashed by 36.02% to $6.4 million in 2022, then plummeted by 43.69% to $3.6 million in 2023.
  • Business Quant data shows Shares Repurchased for MED at $3.6 million in Q1 2023, $6.4 million in Q4 2022, and $110.0 million in Q2 2022.